The Cardiac Amyloidosis Program at Tufts Medical Center provides efficient and expert diagnosis and treatment for patients with suspected or established cardiac amyloidosis.
The resources of the CardioVascular Center provide state-of-the art imaging for the diagnosis of cardiac amyloidosis, including technetium pyrophosphate (PYP) scanning, cardiac MRI and echocardiography.
For patients with known cardiac amyloidosis, we provide expert care including amyloid-specific therapies and management of heart failure.
We work closely with patients’ local physicians to coordinate care and bring care to Boston only when necessary. In Boston, we collaborate with faculty from the John C. Davis Myeloma and Amyloid Program in the Tufts Medical Center Cancer Center for patients who have suspected or known light chain (AL) cardiac amyloidosis.